费尔蒂综合征
医学
内科学
中性粒细胞减少症
毒性
作者
Venu Pararath Gopalakrishnan,J Tirupur Ponnusamy,Sreelakshmi Panginikkod
标识
DOI:10.1093/qjmed/hcad222
摘要
A 55-year-old male with seropositive rheumatoid arthritis (RA) for 15 years presented for evaluation of severe neutropenia (180/microliter). The patient had uncontrolled inflammation on joints for the last 10 years and had been on multiple medications without substantial relief. Physical examination revealed ulnar deviation of metacarpophalangeal joints (i), swam neck deformity (ii), boutonniere deformity (iii) and Z deformity (iv) on hands (Figure 1). Computed tomography scan of abdomen confirmed splenomegaly which was suspected on physical exam (Figure 2). Bone marrow biopsy showed no evidence of dysplasia, had increased immature mononuclear cells with left shift and rare mature neutrophils. Biopsy also showed normal cytogenetics and MPN mutation screen. A diagnosis of felt’s syndrome was made, and the patient was started on rituximab infusion which resulted in substantial improvement of neutrophil count to 1500 per microliter. Hand deformities in rheumatoid arthritis. CT abdomen and pelvis without contrast showing splenomegaly. Felty syndrome is a rare extra-articular manifestation affecting <1% of patients with RA and is characterized by the triad of RA, neutropenia and splenomegaly. Felty syndrome usually occurs in patients with severe, long-standing, erosive and seropositive arthritis. The treatment includes control of inflammatory arthritis using disease-modifying antirheumatic drugs. Splenectomy can be considered in patients who are refractory to medical therapy. G-CSF also can be used to reduce the risk of infections in patients with severe neutropenia. None declared.
科研通智能强力驱动
Strongly Powered by AbleSci AI